Nuplazid.com

NUPLAZID. Is the only FDA approved treatment for hallucinations & delusions associated with PD psychosis. See Important Safety Information...

Never miss Nuplazid.com updates: Start reading the news feed of NUPLAZID right away! Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Nuplazid.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to NUPLAZID

Subscribe to related news

Clinical Pharmacology Corner: FDA Approves NUPLAZID® (Pimavanserin)
via elbiruniblogspotcom.blogspot

FDA Approves NUPLAZID® (Pimavanserin) for the Treatment of Hallucinations and Delusions Associated With Parkinson’s Disease Psychosis On April 29, 2016, the FDA approved NUPLAZID (pimavanserin) immediate release tablets for the treatment of hallucinations...
FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) – The First Drug Approved for the Treatment of Hallucinati...
via military-technologies

SAN DIEGO--(satPRNews.com)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company FOCused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today...
Buy These 3 Stocks with Strong Insider Buying
via investorsalley

Even with the market rallying back to positive for the year, insiders in these three stocks have kept buying shares at a rapid pace. These strong votes of confidence by upper management are encouraging to investors looking for value in this market. ...
The 2nd edition of The holistic Prevention, Management and Treatment of Dementia under The Microscope of Conventional Me...
via kylejnorton.blogspot

Kyle J. Norton (Scholar) Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news...
Why I'm Still Optimistic On LymPro and Amarantus Bio
via bionapcfa.blogspot

By Jason Napodano, CFA Amarantus BioScience Holdings (OTC:AMBS) stock has been on a wild ride over the past two months. The shares were trading at only 7 cents in May 2014 before news broke that the company would be presenting data on LymPro, the company...

Nuplazid.com popular pages

Parkinson’s-related Hallucinations & Delusions Treatment - NUPLAZID® (pimavanserin)

NUPLAZID® is the only FDA-approved treatment for hallucinations & delusions associated with Parkinson's disease psychosis (PDP). See Important Safety Information and full Prescribing Information inclu...